Shares of Progyny PGNY were flat in after-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share were up 66.67% over the past year to $0.05, which were in line with the estimate of $0.05.
Revenue of $98,928,000 rose by 61.66% from the same period last year, which beat the estimate of $92,590,000.
Looking Ahead
Progyny hasn't issued any earnings guidance for the time being.
Revenue guidance hasn't been issued by the company for now.
How To Listen To The Conference Call
Date: Nov 05, 2020
Time: 04:45 PM
ET Webcast URL: https://edge.media-server.com/mmc/p/fm7d7u3t
Price Action
Company's 52-week high was at $36.50
52-week low: $15.59
Price action over last quarter: Up 6.45%
Company Description
Progyny Inc is a United States based company engaged in specializing in fertility and family building benefits solutions. Its clients include employers across various industries.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
